Javelin Says Hospira Breached $145M Merger Deal

Law360, New York (June 3, 2010, 3:51 PM EDT) -- Javelin Pharmaceuticals Inc. is seeking to force Hospira Inc. to complete its proposed $145 million acquisition of the painkiller company and make good on its alleged promise to furnish Javelin with a $2 million loan.

Cambridge, Mass.-based Javelin filed a lawsuit against Hospira and Discus Acquisition Corp. — a Hospira subsidiary formed to acquire Javelin — in the Delaware Court of Chancery on Wednesday, accusing Hospira of breaching an April 17 merger agreement.

In April, Hospira and Javelin announced they had entered into a merger agreement...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.